Amedeo Smart

Free Medical Literature Service



Venous Thrombosis

  Free Subscription

Articles published in
    February 2024
  1. MAUGHAN BC, Jarman AF, Redmond A, Geersing GJ, et al
    Pulmonary embolism.
    BMJ. 2024;384:e071662.
    >> Share

    October 2023
  2. BOYCE S, McFarlane E, Harrison S, McCormack T, et al
    Diagnosis of venous thromboembolic diseases in people with covid-19: summary of updated NICE guidance.
    BMJ. 2023;383:p2204.
    >> Share

    September 2023
    NSAIDs, hormonal contraception, and venous thromboembolism.
    BMJ. 2023;382:p1990.
    >> Share

  4. MEAIDI A, Mascolo A, Sessa M, Toft-Petersen AP, et al
    Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study.
    BMJ. 2023;382:e074450.
    >> Share

    June 2023
  5. GUNTUPALLI SR, Spinosa D, Wethington S, Eskander R, et al
    Prevention of venous thromboembolism in patients with cancer.
    BMJ. 2023;381:e072715.
    >> Share

    November 2022
  6. AGENO W, Bertu L, Bucherini E, Camporese G, et al
    Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial.
    BMJ. 2022;379:e072623.
    >> Share

    October 2022
  7. LI X, Burn E, Duarte-Salles T, Yin C, et al
    Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US.
    BMJ. 2022;379:e071594.
    >> Share

    April 2022
  8. HO FK, Pell JP
    Thromboembolism and bleeding after covid-19.
    BMJ. 2022;377:o817.
    >> Share

  9. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Jerndal H, et al
    Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study.
    BMJ. 2022;377:e069590.
    >> Share

    March 2022
  10. MARCUCCI M, Etxeandia-Ikobaltzeta I, Yang S, Germini F, et al
    Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.
    BMJ. 2022;376:e066785.
    >> Share

    August 2021
  11. HIPPISLEY-COX J, Patone M, Mei XW, Saatci D, et al
    Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    BMJ. 2021;374:n1931.
    >> Share

    June 2021
  12. BLANK M, Collas O, Hirji H
    A young man with shortness of breath.
    BMJ. 2021;373:n1313.
    >> Share

  13. KOVACS MJ, Wells PS, Anderson DR, Lazo-Langner A, et al
    Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.
    BMJ. 2021;373:n1205.
    >> Share

    May 2021
  14. HORNER D, Goodacre S, Davis S, Burton N, et al
    Which is the best model to assess risk for venous thromboembolism in hospitalised patients?
    BMJ. 2021;373:n1106.
    >> Share

  15. PERERA R, Fletcher J
    Thromboembolism and the Oxford-AstraZeneca vaccine.
    BMJ. 2021;373:n1159.
    >> Share

  16. POTTEGARD A, Lund LC, Karlstad O, Dahl J, et al
    Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.
    BMJ. 2021;373:n1114.
    >> Share

    January 2021
  17. SALMAN D, Vishnubala D, Le Feuvre P, Beaney T, et al
    Returning to physical activity after covid-19.
    BMJ. 2021;372:m4721.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016